Literature DB >> 10651186

Negative chronotropic and inotropic effects of class I antiarrhythmic drugs assessed in isolated canine blood-perfused sinoatrial node and papillary muscle preparations.

A Sugiyama1, S Takehana, R Kimura, K Hashimoto.   

Abstract

The present study was designed to assess the negative chronotropic and inotropic effects of 10 class I antiarrhythmic drugs, using isolated canine blood-perfused sinoatrial node and papillary muscle preparations. Each drug showed negative chronotropic and inotropic effects in a dose-related manner. The potency of the suppressive effect on the sinoatrial automaticity was in the order of aprindine, quinidine, flecainide, lidocaine, mexiletine, cibenzoline, disopyramide, procainamide, tocainide, and phenytoin, while the effect on the ventricular contraction was in the order of aprindine, flecainide, cibenzoline, lidocaine, mexiletine, disopyramide, tocainide, phenytoin, quinidine, and procainamide. The differences in the suppressive effects could not necessarily be explained by their subclassification, based either on action potential duration or kinetic properties of dissociation or association with sodium channels. On the other hand, we found a good correlation between the negative inotropic effects of class I drugs in this study and the canine antiarrhythmic plasma concentrations for the digitalis- and coronary ligation-induced ventricular arrhythmia models in our previous studies. However, the negative chronotropic effects of the drugs showed a poor correlation with the antiarrhythmic plasma drug concentrations. The data shown in this paper may provide a convenient guideline for predicting acute cardiosuppressive effects of antiarrhythmic drugs, especially in patients with reduced cardiac function.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10651186     DOI: 10.1007/bf02481749

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  23 in total

1.  Mechanisms of negative inotropic effects of class Ic antiarrhythmic agents: comparative study of the effects of flecainide and pilsicainide on intracellular calcium handling in dog ventricular myocardium.

Authors:  Y Kihara; M Inoko; N Hatakeyama; Y Momose; S Sasayama
Journal:  J Cardiovasc Pharmacol       Date:  1996-01       Impact factor: 3.105

2.  Electrophysiological effects of procaine in rabbit sino-atrial node cells.

Authors:  H Satoh; K Hashimoto
Journal:  Jpn J Pharmacol       Date:  1986-01

3.  Negative inotropic effects of tetrodotoxin and seven class 1 antiarrhythmic drugs in relation to sodium channel blockade.

Authors:  P Honerjäger; E Loibl; I Steidl; G Schönsteiner; K Ulm
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-02       Impact factor: 3.000

Review 4.  The generation of electric currents in cardiac fibers by Na/Ca exchange.

Authors:  L J Mullins
Journal:  Am J Physiol       Date:  1979-03

5.  Pharmacological evidence of autonomic nerve activities in canine papillary muscle.

Authors:  M Endoh; K Hashimoto
Journal:  Am J Physiol       Date:  1970-05

6.  Evaluation of negative inotropic and antiarrhythmic effects of class 1 antiarrhythmic drugs.

Authors:  T Nawada; Y Tanaka; S Hirai; I Hisatome; J Hasegawa; H Kotake; H Mashiba
Journal:  Int J Clin Pharmacol Ther       Date:  1994-07       Impact factor: 1.366

7.  Comparison of cardiovascular effects of a novel class Ic antiarrhythmic agent, NIK-244, with those of flecainide in isolated canine heart preparations cross-circulated with a donor dog.

Authors:  A Sugiyama; S Motomura; K Hashimoto
Journal:  Jpn J Pharmacol       Date:  1991-05

8.  Effects of antiarrhythmic drugs on canine ventricular arrhythmia models: which electrophysiological characteristics of drugs are related to their effectiveness?

Authors:  K Hashimoto; A Haruno; T Matsuzaki; A Sugiyama; K Akiyama
Journal:  Cardiovasc Drugs Ther       Date:  1991-08       Impact factor: 3.727

9.  Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial.

Authors:  D S Echt; P R Liebson; L B Mitchell; R W Peters; D Obias-Manno; A H Barker; D Arensberg; A Baker; L Friedman; H L Greene
Journal:  N Engl J Med       Date:  1991-03-21       Impact factor: 91.245

10.  Utilization of an isolated, blood-perfused canine papillary muscle preparation as a model to assess efficacy and adversity of class I antiarrhythmic drugs.

Authors:  A Sugiyama; S Motomura; K Hashimoto
Journal:  Jpn J Pharmacol       Date:  1994-11
View more
  1 in total

1.  Mechanisms of flecainide induced negative inotropy: An in silico study.

Authors:  Pei-Chi Yang; Wayne R Giles; Luiz Belardinelli; Colleen E Clancy
Journal:  J Mol Cell Cardiol       Date:  2021-05-15       Impact factor: 5.000

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.